- Home
- KNSA vs KW Comparison
KNSA vs KW Comparison
Compare KNSA & KW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- KW
- Stock Information
- Founded
- KNSA 2015
- KW 1977
- Country
- KNSA United Kingdom
- KW United States
- Employees
- KNSA N/A
- KW N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- KW Real Estate
- Sector
- KNSA Health Care
- KW Finance
- Exchange
- KNSA Nasdaq
- KW Nasdaq
- Market Cap
- KNSA 1.6B
- KW 1.4B
- IPO Year
- KNSA 2018
- KW 1992
- Fundamental
- Price
- KNSA $22.52
- KW $8.46
- Analyst Decision
- KNSA Strong Buy
- KW Hold
- Analyst Count
- KNSA 6
- KW 1
- Target Price
- KNSA $37.17
- KW $13.00
- AVG Volume (30 Days)
- KNSA 684.1K
- KW 792.1K
- Earning Date
- KNSA 04-22-2025
- KW 05-07-2025
- Dividend Yield
- KNSA N/A
- KW 5.58%
- EPS Growth
- KNSA N/A
- KW N/A
- EPS
- KNSA N/A
- KW N/A
- Revenue
- KNSA $423,239,000.00
- KW $511,600,000.00
- Revenue This Year
- KNSA $37.21
- KW $32.54
- Revenue Next Year
- KNSA $1.38
- KW $45.44
- P/E Ratio
- KNSA N/A
- KW N/A
- Revenue Growth
- KNSA 56.60
- KW N/A
- 52 Week Low
- KNSA $16.56
- KW $8.02
- 52 Week High
- KNSA $28.15
- KW $11.88
- Technical
- Relative Strength Index (RSI)
- KNSA 60.12
- KW 38.04
- Support Level
- KNSA $22.62
- KW $8.68
- Resistance Level
- KNSA $23.42
- KW $9.07
- Average True Range (ATR)
- KNSA 0.75
- KW 0.27
- MACD
- KNSA -0.01
- KW -0.04
- Stochastic Oscillator
- KNSA 68.88
- KW 10.71
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About KW Kennedy-Wilson Holdings Inc.
Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.